Chief Accounting Officer
Sun, Aug 9, 2026
16d ago
exercised or converted securities in BSEM
970 shares @ $0.00
Decreased holdings by -12.50%
Net across this filing: +1.50% (+970 shares)
BSEMBioStem Technologies, Inc.
ManufacturingBiological Products, (No Diagnostic Substances)
1D0.00%
1W+24.44%
1M-2.24%
3M-1.71%
6M—
1Y—